Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

A new study has created the first single-cell map of how DNA is regulated and organized inside different cell-types of human ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

Light physical activity was associated with improved femoral neck and total hip BMD among young adults with obesity and overweight.